• About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV
Saturday, February 4, 2023
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
No Result
View All Result

2022 Access to Medicine Index ranks top global pharmaceutical firms

November 29, 2022
Reading Time: 2 mins read
ShareShareShareShare

The 2022 Access to Medicine Index has ranked the top 20 pharmaceutical companies globally. GSK, Johnson & Johnson and AstraZeneca took the top three positions on the list.

AstraZeneca’s top three position in the 2022 Access to Medicine Index (AtMI) reflects the company’s leading work to strengthen global health systems, as well as increase equitable and affordable patient access to life-changing treatments.

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: “We believe it’s vital everyone has access to affordable, sustainable, and innovative healthcare, particularly in low- and middle-income countries. This ranking reflects AstraZeneca’s strategic focus on improving access to medicines and to the crucial work with our partners to strengthen health system resilience.”

AtMI is an independent ranking of 20 of the world’s largest pharmaceutical companies and evaluates their impact on improving access to medicine in low- and middle-income countries (LMICs). It focuses on three technical areas: Governance of Access; Research and Development (R&D); and Product Delivery. AstraZeneca moved up from 7th to 3rd position after performing well across all three technical areas.

AstraZeneca was recognised by AtMI as the industry leader in Product Delivery, noting its application of tailored access strategies for different countries reflecting their income classifications across all product categories. The Company’s approach to patent transparency and sharing of intellectual property assets, using technology transfers, was also highlighted as key to ensuring continuous supply of medicines in LMICs. Furthermore, the AtMI recognised AstraZeneca’s local capacity building initiatives and use of inclusive business models aimed at meeting the access needs of populations at the base of the income pyramid.

AstraZeneca also performed well in the Governance of Access category reflecting robust compliance controls, and also in R&D for its access plans for projects in Phase 2 or 3 of clinical development. Ongoing company initiatives to support access to COVID-19 vaccines via manufacturing, procurement, and distribution agreements in the light of the pandemic were also recognised.

Read more about the delivery of AstraZeneca’s Access to healthcare commitments in the 2021 Sustainability Report and Sustainability Data Summary.

Source: AstraZeneca
ShareTweetSendSend
Previous Post

Ghana Gas celebrates farmers with GHS180,000

Next Post

Bright Simons writes: Ghana’s golden gambit on oil

Related Posts

General

AstraZeneca’s Healthy Heart Africa programme set to expand to 10 more African countries

December 5, 2022
Health

AstraZeneca and partners act for equitable cancer care across Africa

November 10, 2022
General

AstraZeneca partners with CBA to plant over 3 million trees in Ghana

March 24, 2022
Source: https://www.flickr.com/photos/prachatai/
Opinion

From pandemic to endemic: The ethics of vaccine sale profits [Article]

November 15, 2021
Coronavirus vaccination
News

Check out the list of centres for ongoing COVID-19 vaccine rollout

September 24, 2021
Top Stories

COVID vaccinations continue today with AstraZeneca jabs

September 24, 2021
Next Post

Bright Simons writes: Ghana’s golden gambit on oil

TOP STORIES

The Spelling Bee 2023: N’Adom Darko-Asare retains title in impressive style

February 4, 2023

Economic crisis affecting NPP’s campaign message for 2024 – Alan

February 4, 2023

Road Safety Authority advocates for dualisation of major roads to reduce crashes

February 4, 2023
Load More
ADVERTISEMENT
Citinewsroom – Comprehensive News in Ghana

CitiNewsroom.com is Ghana's leading news website that delivers high quality innovative, alternative news that challenges the status quo.

Archives

Download App

Download

Download

  • About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV

© 2021 All Rights Reserved Citi Newsroom.

No Result
View All Result
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos

© 2021 All Rights Reserved Citi Newsroom.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT